Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma (Q39793721)
Jump to navigation
Jump to search
scientific article published on March 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma |
scientific article published on March 2010 |
Statements
1 reference
Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma (English)
1 reference
1 reference
Christian G Stief
1 reference
Andrea Baur-Melnyk
1 reference
Heike Pohla
1 reference
Bernhard Frankenberger
1 reference
Joachim Kopp
1 reference
Gerald Willimsky
1 reference
Antonio Pezzutto
1 reference
Thomas Blankenstein
1 reference
Ralph Oberneder
1 reference
Ronald Frank
1 reference
Michael Siebels
1 reference
Alfons Hofstetter
1 reference
Dolores J Schendel
1 reference
1 March 2010
1 reference
1 reference
21
1 reference
3
1 reference
285-297
1 reference
Identifiers
1 reference
1 reference